Washington, DC (PRWEB) June 17, 2013
When a patient is released from the hospital after a heart attack or other major medical event, he or she may be leaving with one or more new medications that potentially conflict(s) with a pre-existing medication regimen. But who is going to flag any potential drug-to-drug interactions, duplicate therapies, gaps in care or other therapy problems? Three pharmacy benefit experts with considerable experience observing and addressing medication reconciliation issues will review the pros and cons of different strategies in “Post-Discharge Medication Reconciliation Strategies for Health Plans and PBMs,” the upcoming June 26 webinar from Atlantic Information Services, Inc. (AIS).
The more patients bounce from doctor to hospital to other sources of care without an advocate monitoring what medications they’re taking (or not taking), the greater the likelihood of costly hospital readmissions or other unfavorable outcomes, including death. How can health plans and PBMs improve the effectiveness of medication reconciliation? What approaches work best? What outcomes have plan sponsors seen with different programs? And how should medication reconciliation be reimbursed?
In the June 26 webinar, Jan Berger, M.D., M.J., chief medical officer at Silverlink Communications and a longtime advocate of medication therapy management programs, Brian Solow, M.D., F.A.A.F.P., chief medical officer for OptumRx, and Dean T. Parry, R.Ph., director of Pharmacy Clinical Programs at Geisinger Health Plan, will discuss the critical components of medication reconciliation and share strategies to address them. These and other questions will be addressed:
- How can payers and providers measure whether medication reconciliation is effective and includes not just a routine check of prescribed medications, but also patient education and outcomes measurement?
- Which model for staffing and coordinating medication reconciliation efforts works best — and for which types of patient groups and plan sponsors?
- What outcomes have different types of medication reconciliation programs achieved?
- How should payers reimburse for medication reconciliation — and what role can incentives play in making sure this crucial function is done effectively?
- How can payers harness the value of the pharmacist to intervene in issues stemming from multiple prescribers?
- How can integrating medical and pharmacy claims data serve to better manage issues around medication reconciliation?
Visit http://aishealth.com/marketplace/c3p28_062613 for more details and registration information.
Atlantic Information Services, Inc. (AIS) is a publishing and information company that has been serving the health care industry for more than 25 years. It develops highly targeted news, data and strategic information for managers in hospitals, health plans, medical group practices, pharmaceutical companies and other health care organizations. AIS products include print and electronic newsletters, websites, looseleafs, books, strategic reports, databases, webinars and conferences. Learn more at http://AISHealth.com.